scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...628434G |
P356 | DOI | 10.1371/JOURNAL.PONE.0028434 |
P932 | PMC publication ID | 3235119 |
P698 | PubMed publication ID | 22174806 |
P5875 | ResearchGate publication ID | 51884764 |
P50 | author | Maria Grazia Roncarolo | Q56426635 |
Andrea Valle | Q96092257 | ||
Nicola Gagliani | Q97069653 | ||
Tatiana Jofra | Q116997208 | ||
Angela Stabilini | Q116997209 | ||
Manuela Battaglia | Q38642202 | ||
Silvia Gregori | Q38642221 | ||
P2093 | author name string | Mark Atkinson | |
David M Rothstein | |||
P2860 | cites work | A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 |
Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation | Q28752432 | ||
FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
CTLA-4 up-regulation plays a role in tolerance mediated by CD45. | Q31793582 | ||
Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant | Q33604471 | ||
Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. | Q34242160 | ||
IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells | Q34318928 | ||
Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. | Q34966662 | ||
Interleukin-10 therapy--review of a new approach | Q35139563 | ||
Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells | Q52010476 | ||
Prevention and reversal of renal allograft rejection by antibody against CD45RB | Q60079374 | ||
CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection | Q73160715 | ||
Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions | Q79858864 | ||
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10 | Q80785928 | ||
Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells | Q81191262 | ||
G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse | Q81648171 | ||
Towards the identification of biomarkers of transplantation tolerance | Q83956260 | ||
Tregs and transplantation tolerance | Q35951541 | ||
The pleiotropic effects of mTor inhibitors | Q35981412 | ||
Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy | Q36010833 | ||
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells | Q36842568 | ||
Granulocyte colony-stimulating factor for the induction of T-cell tolerance. | Q36882397 | ||
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. | Q36891917 | ||
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms | Q36936238 | ||
Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells | Q37106740 | ||
Regulatory T cells after organ transplantation: where does their action take place? | Q37220729 | ||
In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression | Q37273329 | ||
Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs | Q37400370 | ||
Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress | Q37602218 | ||
Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go? | Q37765648 | ||
An update on regulatory T cells in transplant tolerance and rejection. | Q37777645 | ||
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 | ||
Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells | Q45858705 | ||
Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. | Q45889459 | ||
Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. | Q47262629 | ||
Cutting edge: transplantation tolerance through enhanced CTLA-4 expression | Q47368720 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sirolimus | Q32089 |
P304 | page(s) | e28434 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation | |
P478 | volume | 6 |
Q38666452 | Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets |
Q28289781 | Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells |
Q35665104 | Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice |
Q38365254 | Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy. |
Q40278618 | Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated |
Q39076791 | IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo |
Q37077578 | IL-10 induction from implants delivering pancreatic islets and hyaluronan |
Q38574966 | In vivo induction of regulatory T cells for immune tolerance in hemophilia |
Q56895782 | Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice |
Q41275399 | Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice. |
Q36655788 | Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity. |
Q33729446 | Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis |
Q38035848 | The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function |
Q92916933 | The promise of CD4+FoxP3+ regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation |
Q42208547 | The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts |
Q52717429 | Tr1 cell immunotherapy promotes transplant tolerance via de novo Tr1 cell induction in mice and is safe and effective during acute viral infection. |
Q42782622 | Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen |
Search more.